HK1000244A1 - Use of naphthoxazines - Google Patents
Use of naphthoxazinesInfo
- Publication number
- HK1000244A1 HK1000244A1 HK97101777A HK97101777A HK1000244A1 HK 1000244 A1 HK1000244 A1 HK 1000244A1 HK 97101777 A HK97101777 A HK 97101777A HK 97101777 A HK97101777 A HK 97101777A HK 1000244 A1 HK1000244 A1 HK 1000244A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- naphthoxazines
- schaemia
- cerebral
- stroke
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898928316A GB8928316D0 (en) | 1989-12-14 | 1989-12-14 | Improvements in or relating to organic compounds |
DE19904003262 DE4003262A1 (de) | 1990-02-03 | 1990-02-03 | Neues naphthoxazin, seine herstellung und verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1000244A1 true HK1000244A1 (en) | 1998-02-13 |
Family
ID=25889734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK97101777A HK1000244A1 (en) | 1989-12-14 | 1997-09-15 | Use of naphthoxazines |
Country Status (15)
Country | Link |
---|---|
US (1) | US5190941A (xx) |
EP (1) | EP0433239B1 (xx) |
JP (1) | JPH0825880B2 (xx) |
KR (1) | KR0182276B1 (xx) |
AT (1) | ATE113040T1 (xx) |
AU (1) | AU639512B2 (xx) |
CA (1) | CA2032132A1 (xx) |
CY (1) | CY2065B1 (xx) |
DE (1) | DE69013476T2 (xx) |
DK (1) | DK0433239T3 (xx) |
ES (1) | ES2063328T3 (xx) |
HK (1) | HK1000244A1 (xx) |
HU (1) | HU214591B (xx) |
IE (1) | IE66143B1 (xx) |
PT (1) | PT96178B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000124A1 (en) * | 1992-06-22 | 1994-01-06 | Eckard Weber | Glycine receptor antagonists and the use thereof |
DE4329776A1 (de) * | 1993-09-03 | 1995-03-09 | Sandoz Ag | Naphthoxazine, ihre Herstellung und Verwendung |
BRPI0920246A2 (pt) | 2008-10-17 | 2017-06-27 | Winconsin Alumni Res Foundation | método de preparação de alfa-beta peptídios biologicamente ativos. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4540691A (en) * | 1984-04-13 | 1985-09-10 | Nelson Research & Development Co. | Dopamine agonists and use thereof |
HU193979B (en) * | 1984-06-12 | 1987-12-28 | Sandoz Ag | Process for producing naphtoxazine derivatives and pharmaceutical compositions containing them |
EP0233728A1 (en) * | 1986-02-11 | 1987-08-26 | Takeda Chemical Industries, Ltd. | 1,4-Benzoxazine derivatives their production and use |
-
1990
- 1990-11-30 HU HU908017A patent/HU214591B/hu not_active IP Right Cessation
- 1990-12-11 ES ES90810968T patent/ES2063328T3/es not_active Expired - Lifetime
- 1990-12-11 DE DE69013476T patent/DE69013476T2/de not_active Expired - Fee Related
- 1990-12-11 DK DK90810968.9T patent/DK0433239T3/da active
- 1990-12-11 AT AT90810968T patent/ATE113040T1/de not_active IP Right Cessation
- 1990-12-11 EP EP90810968A patent/EP0433239B1/en not_active Expired - Lifetime
- 1990-12-12 US US07/626,352 patent/US5190941A/en not_active Expired - Fee Related
- 1990-12-12 CA CA002032132A patent/CA2032132A1/en not_active Abandoned
- 1990-12-12 AU AU67975/90A patent/AU639512B2/en not_active Ceased
- 1990-12-13 JP JP2410720A patent/JPH0825880B2/ja not_active Expired - Lifetime
- 1990-12-13 PT PT96178A patent/PT96178B/pt active IP Right Grant
- 1990-12-13 KR KR1019900020463A patent/KR0182276B1/ko not_active IP Right Cessation
- 1990-12-13 IE IE449790A patent/IE66143B1/en not_active IP Right Cessation
-
1997
- 1997-09-15 HK HK97101777A patent/HK1000244A1/xx not_active IP Right Cessation
-
1998
- 1998-06-12 CY CY9802065A patent/CY2065B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CY2065B1 (en) | 1998-06-12 |
ES2063328T3 (es) | 1995-01-01 |
CA2032132A1 (en) | 1991-06-15 |
PT96178B (pt) | 1998-04-30 |
DE69013476T2 (de) | 1995-05-04 |
IE66143B1 (en) | 1995-12-13 |
PT96178A (pt) | 1991-09-30 |
ATE113040T1 (de) | 1994-11-15 |
KR910011261A (ko) | 1991-08-07 |
DK0433239T3 (da) | 1995-01-16 |
HU908017D0 (en) | 1991-06-28 |
JPH03271223A (ja) | 1991-12-03 |
HUT57749A (en) | 1991-12-30 |
KR0182276B1 (ko) | 1999-05-01 |
AU639512B2 (en) | 1993-07-29 |
JPH0825880B2 (ja) | 1996-03-13 |
EP0433239B1 (en) | 1994-10-19 |
DE69013476D1 (de) | 1994-11-24 |
HU214591B (hu) | 1998-04-28 |
AU6797590A (en) | 1991-06-20 |
EP0433239A1 (en) | 1991-06-19 |
US5190941A (en) | 1993-03-02 |
IE904497A1 (en) | 1991-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59407626D1 (de) | Sulfonylaminopyrimidine, ihre Herstellung und Verwendung als Heilmittel | |
EP0562049A4 (en) | Novel 4-arylpiperazines and 4-arylpiperidines | |
TW222000B (xx) | ||
GR3005470T3 (xx) | ||
TW283642B (xx) | ||
ES2194102T3 (es) | Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
CY2065B1 (en) | Use of naphthoxazines | |
DE68911237D1 (de) | Nichtionische Trijodbenzin-Verbindungen und diese enthaltende Kontrastmittel. | |
DK0623620T3 (da) | 5-HT3-pyrrolopyrazinderivater | |
HUT71512A (en) | N-(3-chlorophenyl)-piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them | |
ES2004215A6 (es) | Procedimiento para preparar quinazolinas tetraciclicas | |
FI960588A0 (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä | |
EP0377127A3 (de) | Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel | |
FI882388A0 (fi) | 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin. | |
HU913212D0 (en) | New ergoline derivatives | |
IT1255474B (it) | Derivati 1,4-benzotiazinici ad attivita' calcio antagonista |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |